Avicanna Inc. (TSX: AVCN)
Canada
· Delayed Price · Currency is CAD 0.330
+0.010 (3.13%)
Dec 27, 2024, 3:59 PM EST
Avicanna Revenue
Avicanna had revenue of 6.27M CAD in the quarter ending September 30, 2024, with 0.34% growth. This brings the company's revenue in the last twelve months to 24.90M, up 109.66% year-over-year. In the year 2023, Avicanna had annual revenue of 16.79M with 314.82% growth.
Revenue (ttm)
24.90M
Revenue Growth
+109.66%
P/S Ratio
1.26
Revenue / Employee
286.16K
Employees
87
Market Cap
36.37M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb Corporation | 6.33B |
| Bausch Health Companies Inc. | 12.80B |
| Tilray Brands, Inc. | 1.10B |
| WELL Health Technologies Corp. | 957.69M |
| Curaleaf Holdings, Inc. | 1.83B |
| dentalcorp Holdings Ltd. | 1.51B |
| Sienna Senior Living Inc. | 867.55M |
| Cronos Group Inc. | 150.26M |